Search for: "May Chen"
Results 281 - 300
of 1,561
Sort by Relevance
|
Sort by Date
6 May 2022, 8:10 am
At the end of last year, Alibaba security researcher Chen Zhoujun discovered a critical software vulnerability in Log4j, an open-source logging library, and reported it to the Apache Software Foundation. [read post]
5 May 2022, 3:46 pm
Contents include: International Legal Theory Tilmann Altwicker, Social justice and the judicial interpretation of international equal protection law Li Chen, A forgotten proponent of a league of nations and his contributions to international law Oren Perez, Transnational networked authority International Law and PracticeDiego Zannoni, Out of sight, out of mind? [read post]
3 May 2022, 1:55 am
The country’s investments in artificial intelligence, biotechnology, and telecommunications (5G), and other components of the so-called “fourth industrial revolution” have left U.S. policymakers concerned that the U.S. may be losing ground and led to calls to increase direct government support for these industries.[5] Most of the proposals focus on providing additional funding, often in the form of industry-specific subsidies, without considering the baseline tax… [read post]
28 Apr 2022, 9:05 pm
First, hiding information may result in an investigation by SEC and trigger lawsuits. [read post]
23 Apr 2022, 5:36 pm
(James Chen, Investopedia). [read post]
21 Apr 2022, 9:32 am
For article 31 of the VCLT states that it is the later agreements which may be used, if needed, to interpret the meaning of the provisions of a previous international treaty. [read post]
20 Apr 2022, 5:01 am
Reports indicate that as part of its inquiry into Zhou, the CCDI may be expanding its investigation to examine Ant Group’s dealings with other state parties. [read post]
18 Apr 2022, 7:52 am
The filing argued that Musk’s comments on the tweets may potentially confuse jurors and prejudice a jury decision. [read post]
15 Apr 2022, 11:42 pm
(Id.; James Chen, Investopedia). [read post]
14 Apr 2022, 5:54 am
As former Justice Department attorney Edgar Chen persuasively argued in Just Security in March, closing these loopholes can and should be done immediately to strengthen the country’s ability to respond with all the tools at its disposal. [read post]
8 Apr 2022, 9:06 pm
In this instance, Chen contends that “pressure for heightened regulatory procedure functioned as a shield against expanding rights. [read post]
7 Apr 2022, 6:48 am
The Japan Patent Office may reach a conclusion sometime this year if the parties do not settle. [read post]
6 Apr 2022, 9:52 am
‘These interviews are foreseen to be ongoing until May. [read post]
1 Apr 2022, 2:07 pm
More than 200 of these companies may be subject to delisting under the HFCAA. [read post]
30 Mar 2022, 10:58 am
A new source of conflict at the EPO may be the start of a ‘professional mobility’ project called for by the EPO management. [read post]
30 Mar 2022, 4:31 am
They also submitted that any of these substances may be used for the purpose of calculating the time by which an extension of term application must be filed under section 71(2), and it is for the patentee to nominate the substance. [read post]
30 Mar 2022, 12:15 am
Last year, the California legislature enacted AB 663 (Chen) in order to provide California corporations with greater flexibility to hold virtual-only meetings of shareholders. [read post]
23 Mar 2022, 10:47 am
The client may also be bound by ratification. [read post]
22 Mar 2022, 4:38 am
Where, as in this case, the patent is for a particular drug, ezetimibe, and the claims in the patent teach that the application in human medicine may be for the use of that drug alone or in combination with another drug, here, simvastatin, a drug in the public domain, can an SPC be granted under Article 3(a) of the Regulation only for a product comprising ezetimibe, a monotherapy, or can an SPC also be granted for any or all of the combination products identified in the claims in the… [read post]
21 Mar 2022, 4:25 am
Although the title of this blog may sound trite to most readers, it may still be of interest to briefly discuss a recent case where this topic was discussed before the Spanish courts in the context of a judicial patent dispute between Erasmus Universiteit Medisch Centrum Rotterdam (“Erasmus) and its licensee, on the one hand, and two companies named Vitro S.A. [read post]
